ArticlePloS one2024
Antibacterial effects of thyme oil loaded solid lipid and chitosan nano-carriers against Salmonella Typhimurium and Escherichia coli as food preservatives.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Thymol Chemotype Thymus vulgaris L. Hydrolate: Volatile Chemical Fraction Composition and Antimicrobial Activity Against Bacterial and Fungal Pathogens.Chemistry & biodiversity · 2026Article
- Chitosan and Solid Lipid Nanoparticles as Nano-carriers of Chamomile oil Against S. aureus and P. aeruginosa for Wound Healing.Current microbiology · 2026Article
- Antibacterial Packaging for Cheese Based on Carboxymethyl Cellulose Composite with Zinc Oxide and Thyme Essential Oil.Foods (Basel, Switzerland) · 2026Article
- Sustainable Applications of Thymol: Advances in Formulation Technologies, Drug Delivery Systems, and Food Preservation Strategies.Food science & nutrition · 2026Review
- Nano-encapsulated Melissa officinalis Essential Oil and Its Antibacterial Effects Against Multi Drug Resistant E. coli and K. pneumonia.Current microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesEscherichia coli and Salmonella Typhimurium are frequent causes of foodborne illness affecting many people annually. In order to develop natural antimicrobial agents against these microorganisms, thyme oil (TO) was considered as active antibacterial ingredient. TO contains various bioactive compounds that exhibit antimicrobial properties. To increase the antibacterial effects and stability of thyme oil, two promising carrier systems, solid lipid nanoparticles (SLN) and chitosan nanoparticles have been fabricated in this study.
methodsNanoparticles were made using natural-based lipids and polymers by a probe sonication method. They were characterized using infrared spectrometry (FTIR), transmission electron microscopy (TEM), particle size, cytotoxicity, etc. Antibacterial effects of TO, thyme oil loaded in SLN (TO-SLN) and thyme oil loaded in chitosan nanoparticle (TO-CH) was evaluated against E. coli and S. typhimurium using Minimum inhibitory/bactericidal concentrations (MIC/MBC) determination. Encapsulation efficiency (EE%) and drug release profile were also studied in vitro.
resultsTEM analysis revealed spherical/ovoid-shaped particles with clear edges. TO-SLN had an average size of 42.47nm, while TO-CH had an average size of 144.8nm. The Encapsulation efficiency of TO-CH and TO-SLN nanoparticles were about 81.6±1% and 73.4±1%, respectively. Results indicated 92% cumulative release in TO-CH in comparison with 88% in TO-SLN in 72 h. MIC against E. coli and S. typhimurium for TO-CH, TO-SLN, and pure TO were 4 and 1.5 μg/mL, 60 and 40 μg/mL, and 180-150 μg/mL, respectively.
conclusionNanoencapsulation of thyme oil significantly potentiated its antimicrobial effects. TO-CH exhibited a significantly higher antibacterial effect compared to TO-SLN (6-fold) and pure thyme oil (more than 10-fold).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.